Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.448EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.1 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.120.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.528EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.91 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.383EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.196EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.117EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.323EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used